These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3807833)

  • 41. Calcium entry-blockade with verapamil in cyclosporine A plus ischemia induced acute renal failure in rats.
    Iaina A; Herzog D; Cohen D; Gavendo S; Kapuler S; Serban I; Schiby G; Eliahou HE
    Clin Nephrol; 1986; 25 Suppl 1():S168-70. PubMed ID: 3708928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of verapamil on calcium transport and uptake in segments of rat intestine.
    Pento JT; Johnson ME
    Pharmacology; 1983; 27(6):343-9. PubMed ID: 6672844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of calcium channel blockers in protection against experimental renal injury.
    Schrier RW
    Am J Med; 1991 May; 90(5A):21S-26S. PubMed ID: 2039016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
    Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
    Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS; Jones G
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1,25-Dihydroxyvitamin D3-mediated vesicular transport of calcium in intestine: time-course studies.
    Nemere I; Norman AW
    Endocrinology; 1988 Jun; 122(6):2962-9. PubMed ID: 3371269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium transport in the ileum of uremic rats.
    Koller M; Binswanger U
    Am J Physiol; 1982 Feb; 242(2):G128-34. PubMed ID: 7065139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Derangements in acetylcholine metabolism in brain synaptosomes in chronic renal failure.
    Ni Z; Smogorzewski M; Massry SG
    Kidney Int; 1993 Sep; 44(3):630-7. PubMed ID: 8231038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple test of intestinal absorption of calcium in rats.
    Rubinger D; Krause I; Alcoby-Gibbs M; Popovtzer MM
    Nephron; 1991; 57(2):206-9. PubMed ID: 2020349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The duodenal mucosa in patients with renal failure: response to 1,25(OH)2D3.
    Goldstein DA; Horowitz RE; Petit S; Haldimann B; Massry SG
    Kidney Int; 1981 Feb; 19(2):324-31. PubMed ID: 6894470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic parathyroid hormone excess in vivo increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure.
    Smogorzewski M; Koureta P; Fadda GZ; Perna AF; Massry SG
    J Am Soc Nephrol; 1991 Apr; 1(10):1162-8. PubMed ID: 1768811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Verapamil prevents chronic renal failure-induced abnormalities in lipid metabolism.
    Akmal M; Perkins S; Kasim SE; Oh HY; Smogorzewski M; Massry SG
    Am J Kidney Dis; 1993 Jul; 22(1):158-63. PubMed ID: 8322779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Verapamil protects against progression of experimental chronic renal failure.
    Harris DC; Hammond WS; Burke TJ; Schrier RW
    Kidney Int; 1987 Jan; 31(1):41-6. PubMed ID: 3560644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing the intestinal absorption of calcium and phosphorus following renal transplantation.
    Walker GS; Peacock M; Marshall DH; Giles GR; Davison AM
    Nephron; 1980; 26(5):225-9. PubMed ID: 6999370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure.
    Amann K; Hofstetter J; Câmpean V; Koch A; Gross ML; Veelken R; Ritz E
    Virchows Arch; 2006 Aug; 449(2):207-14. PubMed ID: 16691425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effect of cadmium on calcium absorption from the rat duodenum.
    Sugawara N
    Arch Environ Contam Toxicol; 1977; 5(2):167-75. PubMed ID: 596938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats.
    Fleckenstein-Grün G; Thimm F; Frey M; Matyas S
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):207-13. PubMed ID: 7475044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of verapamil on intestinal calcium transport.
    Wróbel J; Michalska L
    Eur J Pharmacol; 1977 Oct; 45(4):385-7. PubMed ID: 923648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure.
    Müller-Krebs S; Kihm LP; Zeier B; Gross ML; Wieslander A; Haug U; Zeier M; Schwenger V
    Perit Dial Int; 2010; 30(1):35-40. PubMed ID: 20056977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.